Research & Publications
I direct the Program of Applied Translational Research (PATR) which is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, to the development of clinical studies, and to the design of clinical trials. As a critical component of this mission, the Program also seeks to conduct translational research to advance the mechanistic understanding of novel biomarkers to enhance their clinical utility in complex diseases. Our multidisciplinary team is comprised of talented physicians and scientists committed to patient-oriented research and developing solutions in clinical medicine and disease management in the community. The Program aims to combine the creativity, commitment, experience, and skills of our physician-scientists to improve the care of our patients.
The Program develops novel translational research methodologies for assessing biomarker performance and identifies innovative strategies to treat complex clinical disorders, such as peri-operative kidney injury, post-transplantation kidney injury, and hepatorenal and cardiorenal syndromes. A large biosample repository with associated bioinformatics has been established to support all phases of translational research and biomarker development. The Program also recruits and trains students and young scientists in translational research education.
We have created a collaborative environment and actively seek the perspective of those who will use or potentially benefit from our research. Our ultimate goal is to demonstrate that patients directly benefit from the applied science we develop.
Specialized Terms: Acute kidney injury; Novel biomarkers of kidney injury; Translational research
Extensive Research Description
Kidney Diseases; Nephrology; Renal Insufficiency; Biomarkers, Pharmacological; Biostatistics; Translational Medical Research; Acute Kidney Injury
Public Health Interests